A call for prioritizing health and harm reduction in reforming drug policies Drug policy special session AIDS 2014 Melbourne 1300-1400 22 July Dr Alex.

Slides:



Advertisements
Similar presentations
The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP.
Advertisements

Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Key Populations 18 September 2013 Béchir N’Daw, Conseiller régional en Droits de l’Homme et aux Lois, PNUD.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Is harm reduction funding in low and middle income countries in crisis? Susie McLean, International HIV/AIDS Alliance Catherine Cook, Harm Reduction International.
PROMOTING PARLIAMENTARY ACTION ON THE HEALTH & HUMAN RIGHTS OF KEY POPULATIONS 20 th INTERNATIONAL AIDS CONFERENCE MELBOURNE JULY 2014.
Llad Phillips 1 Casual Users, Substance Abusers, and Public Policy The War On Drugs.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
1 Australia's critical role supporting harm reduction in Asia: helping control HIV spread among and from injecting drug users ‘HIV/AIDS in our Region:
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
GAP Report 2014 People left behind: Gay men and other men who have sex with men Link with the pdf, Gay men and other men who have sex with men.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Llad Phillips 1 Casual Users, Substance Abusers, and Public Policy The War On Drugs.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Washington D.C., USA, July 2012www.aids2012.org Addressing the intersection of criminalisation, discrimination and stigma Susan Timberlake Chief,
Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Improving health and protecting human rights Improving health and protecting human rights for individuals, communities, and society Harm reduction and.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Harm Reduction.
Supporting community action on AIDS in developing countries.
1 Current status of harm reduction in Asia International AIDS Conference, Toronto, August 2006 Mr Jimmy Dorabjee Macfarlane Burnet Institute, Melbourne,
Annual report 2010: the state of the drugs problem in Europe.
1 Will drug law reform reduce drug-related harm? 2008 Scotland Future’s Forum 12 March 2008, Parliament House, Edinburgh Dr. Alex Wodak, St. Vincent’s.
1 Controlling HIV among injecting drug users: current status of harm reduction International AIDS Conference, Toronto, 15 August 2006 Dr. Alex Wodak, Sydney,
Security in the Western Hemisphere Illicit Narcotics.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
What lessons should we draw from methamphetamine? Dr Alex Wodak AM, President Australian Drug Law Reform Foundation Tackling Methamphetamine Conference.
The case for developing more effective approaches to alcohol and drug problems Probation and Community Corrections Officers Conference Dr Alex Wodak AM.
What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.
TITTLE: Malawi and homosexuality: politics vs justice Presenter: Gift Trapence Organisation: Centre for the Development of People (CEDEP) Country: Malawi.
HIV Policy for Key Populations: Why does it matter? National Policy Priorities Urban Policy Priorities Jeffrey O’Malley Director, HIV/AIDS Practice, UNDP.
Washington D.C., USA, July 2012www.aids2012.org Condoms as evidence Susan Timberlake Chief, Human Rights and Law Division UNAIDS Secretariat Geneva.
Drug Policies Around the World Portugal: Portugal is one of the most relevant references in the application of alternative strategies to combat drug use,
Global Trends in Decriminalisation: A Quiet Revolution Jamie Bridge International Drug Policy Consortium (IDPC) on behalf of Release Thursday 14th March.
A tale of two drug policies: Portugal and Sweden Alex Stevens, PhD Professor in Criminal Justice.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
The UN General Assembly Special Session on Drugs & the shifting global drug policy landscape Ann Fordham Executive Director 12 th November 2015 Citywide.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 1.
Ireland and International Drug Policy: Lessons and Leadership. Dr. John Collins LSE IDEAS, International Drug Policy Project.
What is the situation in Portugal 14 years after the reformof the drug policy Rita Faria Jorge Quintas School of Criminology – Faculty of Law of the University.
MODULE 2 Effective drug policy What needs to change?
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
Steve Rolles About Transform.
‘Global trends in decriminalisation: A quiet revolution ’ 2.0 Niamh Eastwood Release 16 May 2016.
UNGASS: opportunities to improve drug policy on national, regional and international level Dasha Matyushina-Ocheret Vilnius, February 2, 2016.
‘The War on Drugs: Failures, Impacts, and Alternatives, and the Future of Public Health’ Niamh Eastwood Release 15 November 2014.
U.S. POLICY The Wars on Drugs Participants and processes 2.Strategic content: Goal: Reduce illegal drug use and availability Enforcement > education,
Walking a Thin “Wire”: The Attitudes and Principles of Harm Reduction Niladri Das, MD UPMC St. Margaret Family Medicine Residency Daniel Dejoseph,MD Drexel.
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
MODULE 2 Effective drug policy What needs to change?
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
Amanda Feilding, Beckley Foundation
Addressing Drug Use Together Through a Health Based Approach:
Decriminalisation Policy and the role of the CDT
Niamh Eastwood Executive Director Release
Towards a Conducive Legal and Structural Environment
Strategies for sustainable financing of harm reduction:
Structure and Function of State Government
Beyond drug criminalisation: Why, what and how?
Presentation transcript:

A call for prioritizing health and harm reduction in reforming drug policies Drug policy special session AIDS 2014 Melbourne July Dr Alex Wodak AM 1

Basis current global drug policy? Three international drug treaties Multiple UN agencies Almost every countries participates Participating countries pass laws criminalising all aspects certain drugs Politicians use harsh language refer people who use drugs Majority govt expenditure to supply control 2

Has it worked? Academic debate now over: drug prohibition abject failure* Drug market soared, more dangerous Much harder to protect public health e.g. control HIV among people who inject drugs Increase: deaths, disease, crime, corruption, violence, threats national security Bad policy = good politics * Wodak A, ANZ J Criminology August

‘In addition to criminalizing HIV transmission, many countries impose criminal sanctions for same-sex sex, commercial sex and drug injection. Such laws constitute major barriers to reaching key populations with HIV services. Those behaviours should be decriminalized, and people addicted to drugs should receive health services for the treatment of their addiction’ UN Secretary-General Ban Ki-Moon 4

What needs to change? Threshold question: re-define drugs as predominantly health, social issue Funding implications Base policy on evidence Respect human rights of all Allocate government spending according to return on investment More demand reduction, harm reduction 5

When will it start to change? Change already started First phase: - Netherlands (1970s) -Switzerland (1990s) -Portugal (2001) Current phase: Bolivia left, rejoined 1961 Convention (2011, 2013) Global Commission Drug Policy (2011) UNDP Global Commission on HIV and the Law (2012) 6

When will it start to change? 2 Summit of the Americas (2012), OAS (2013) CO, WA states USA voted 55: 45 % tax, regulate cannabis (2012) Uruguay legislature passed bill legalise cannabis (2013) NZ began regulating new psychoactive substances (2013) Jamaica decriminalised personal ganga (2014) 7

Harm reduction: Initially marginalised 1980s, 1990s Now mainstream global drug policy UN system though still some opposition Evidence now compelling: scientific debate over re needle syringe programs, opioid substitution treatment Concept well defined* # countries supporting, implementing increasing But still too little, too late, only 3% funding needed: impeded drug prohibition * 8

Conclusions: Academic debates now over, political debates continue Harm reduction effective, safe, cost-effective Drug prohibition failed, huge collateral damage, very costly Redefining drugs as predominantly health, social issue the critical step More demand reduction, harm reduction 9